Stock profile

CVS HEALTH CORP (CVS)

CVS · Latest close $86.55 as of Oct 2, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$86.55
As of Oct 2, 2026
Tracked funds holding
10 of 83
2026 Q2 13F filings
Opened / added
1 / 1
vs previous quarter
Trimmed / exited
8
vs previous quarter

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Fairfax Financial Holdings10.63%2,712,000HELD
Davis Advisors5.27%11,865,916TRIMMED (-3.1%)
Patient Capital Management4.19%1,235,505TRIMMED (-9.0%)
Hillman Capital Management4.15%55,475TRIMMED (-17.8%)
Pzena Investment Management3.57%11,769,536TRIMMED (-14.5%)
Dodge & Cox Funds2.71%50,012,765TRIMMED (-3.4%)
Viking Global Investors1.08%3,663,361NEW
Ariel Investments0.75%730,110ADDED (+4.0%)
Oakmark Funds0.05%335,817TRIMMED (-32.0%)
Matrix Asset Advisors0.05%6,175HELD

Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.

Exited this quarter: Maverick Capital, Tweedy Browne.

All institutions · Form 13F

Institutions holding2,075 of 8,857 filers
Long-only filers among them2,062
Change vs 2026 Q1+225 net · 1,631 entered · 1,406 exited
Shares reported, all filers1,130,618,041
Reported value, all filers$115.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 3, 2026.

Politician trading · U.S. House

Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Dividend Growth — Dividends raised for more than 10 years

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Red Flags

· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10

Key figures

· Growth — Latest revenue: $402.1B · 5-yr revenue CAGR: 8.4% · Straight growth years: 15

· Dividend Growth — Dividend per share: 2.66 · Dividend yield: 3.1% · Straight dividend years: 19 · 10-yr dividend growth: 56.5%

· Cash Flow (FCF) — Latest FCF: $7.8B · FCF yield: 7.1% · Positive FCF years: 3

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 3.20 · Operating cash flow: $10.6B · Net income: $1.8B

· Shareholder Yield — Shareholder yield: 3.1% · of which dividends: 3.1% · of which buybacks: 0.0%

· Distress Risk (Altman Z″) — Z″-Score: 0.99 · Working capital / assets: -0.06 · Retained earnings / assets: 0.24 · EBIT / assets: 0.02 · Equity / liabilities: 0.42

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Super-investor 13F BEST — appeared in 12 of the last 20 quarterly lists; latest 2026 Q2, ranked #49 of 50.

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2024 Q2, ranked #44 of 50.

· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2021 Q4, ranked #16 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1457.1%+3.3%+2.8%+0.5%
Share count tripled (3x)366.7%+3.1%+4.8%-1.7%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.